A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
130
50

Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.
James L Khatcheressian, Patricia Hurley, Elissa Bantug, Laura J Esserman, Eva Grunfeld, Francine Halberg, Alexander Hantel, N Lynn Henry, Hyman B Muss, Thomas J Smith,[...]. J Clin Oncol 2013
327
50

A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors.
Rebecca Kristeleit, Geoffrey I Shapiro, Howard A Burris, Amit M Oza, Patricia LoRusso, Manish R Patel, Susan M Domchek, Judith Balmaña, Yvette Drew, Lee-May Chen,[...]. Clin Cancer Res 2017
120
50

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.
Shahneen K Sandhu, William R Schelman, George Wilding, Victor Moreno, Richard D Baird, Susana Miranda, Lucy Hylands, Ruth Riisnaes, Martin Forster, Aurelius Omlin,[...]. Lancet Oncol 2013
346
50

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
W Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry Kuerer, Vicente Valero, Lina Assad, Anna Poniecka, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2007
762
50

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
Brian D Lehmann, Bojana Jovanović, Xi Chen, Monica V Estrada, Kimberly N Johnson, Yu Shyr, Harold L Moses, Melinda E Sanders, Jennifer A Pietenpol. PLoS One 2016
436
50

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
564
50

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
50

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady,[...]. J Clin Oncol 2019
110
50

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
50

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
50

Triple-negative/basal-like breast cancer: review.
Emad A Rakha, Ian O Ellis. Pathology 2009
192
50

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation-Associated Advanced Ovarian Cancer.
Sanjeeve Balasubramaniam, Julia A Beaver, Sara Horton, Laura L Fernandes, Shenghui Tang, Hisani N Horne, Jinzhong Liu, Chao Liu, Sarah J Schrieber, Jingyu Yu,[...]. Clin Cancer Res 2017
67
50

Accurate and exact CNV identification from targeted high-throughput sequence data.
Alex S Nord, Ming Lee, Mary-Claire King, Tom Walsh. BMC Genomics 2011
137
50

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.
Emad A Rakha, Somaia E Elsheikh, Muhammed A Aleskandarany, Hany O Habashi, Andrew R Green, Desmond G Powe, Maysa E El-Sayed, Ahmed Benhasouna, Jean-Sébastien Brunet, Lars A Akslen,[...]. Clin Cancer Res 2009
337
50

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Andrew Tutt, Holly Tovey, Maggie Chon U Cheang, Sarah Kernaghan, Lucy Kilburn, Patrycja Gazinska, Julie Owen, Jacinta Abraham, Sophie Barrett, Peter Barrett-Lee,[...]. Nat Med 2018
295
50

Analyzing survival curves at a fixed point in time.
John P Klein, Brent Logan, Mette Harhoff, Per Kragh Andersen. Stat Med 2007
165
50

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.
Siddhartha Yadav, Chunling Hu, Steven N Hart, Nicholas Boddicker, Eric C Polley, Jie Na, Rohan Gnanaolivu, Kun Y Lee, Tricia Lindstrom, Sebastian Armasu,[...]. J Clin Oncol 2020
13
50

Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers.
Johann de Bono, Ramesh K Ramanathan, Lida Mina, Rashmi Chugh, John Glaspy, Saeed Rafii, Stan Kaye, Jasgit Sachdev, John Heymach, David C Smith,[...]. Cancer Discov 2017
199
50

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Lisa A Carey, E Claire Dees, Lynda Sawyer, Lisa Gatti, Dominic T Moore, Frances Collichio, David W Ollila, Carolyn I Sartor, Mark L Graham, Charles M Perou. Clin Cancer Res 2007
50

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
B Fisher, J Bryant, N Wolmark, E Mamounas, A Brown, E R Fisher, D L Wickerham, M Begovic, A DeCillis, A Robidoux,[...]. J Clin Oncol 1998
50

Iniparib plus chemotherapy in metastatic triple-negative breast cancer.
Joyce O'Shaughnessy, Cynthia Osborne, John E Pippen, Mark Yoffe, Debra Patt, Christine Rocha, Ingrid Chou Koo, Barry M Sherman, Charles Bradley. N Engl J Med 2011
582
50

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
50

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda, Soo-Jung Lee, Shoichiro Ohtani, Young-Hyuck Im, Eun-Sook Lee, Isao Yokota, Katsumasa Kuroi, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim,[...]. N Engl J Med 2017
444
50

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
Yu-Hsiang Chen, Bradley A Hancock, Jeffrey P Solzak, Dumitru Brinza, Charles Scafe, Kathy D Miller, Milan Radovich. NPJ Breast Cancer 2017
45
50

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Jennifer K Litton, Hope S Rugo, Johannes Ettl, Sara A Hurvitz, Anthony Gonçalves, Kyung-Hun Lee, Louis Fehrenbacher, Rinat Yerushalmi, Lida A Mina, Miguel Martin,[...]. N Engl J Med 2018
564
50

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Lancet Oncol 2016
232
50

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.
Tom Walsh, Ming K Lee, Silvia Casadei, Anne M Thornton, Sunday M Stray, Christopher Pennil, Alex S Nord, Jessica B Mandell, Elizabeth M Swisher, Mary-Claire King. Proc Natl Acad Sci U S A 2010
324
50

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival.
Keith N Ogston, Iain D Miller, Simon Payne, Andrew W Hutcheon, Tarun K Sarkar, Ian Smith, A Schofield, Steven D Heys. Breast 2003
451
50

Triple-negative breast cancer: a short review.
Anthony D Elias. Am J Clin Oncol 2010
85
50

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
50

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.
Bradley A Hancock, Yu-Hsiang Chen, Jeffrey P Solzak, Mufti N Ahmad, David C Wedge, Dumitru Brinza, Charles Scafe, James Veitch, Rajesh Gottimukkala, Walt Short,[...]. Breast Cancer Res 2019
9
50

Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer.
Ke-Da Yu, Rui Zhu, Ming Zhan, Angel A Rodriguez, Wei Yang, Stephen Wong, Andreas Makris, Brian D Lehmann, Xi Chen, Ingrid Mayer,[...]. Clin Cancer Res 2013
99
50

The impact of a genetics education program on physicians' knowledge and genetic counseling referral patterns.
Jonathan C Clyman, Fiza Nazir, Sharon Tarolli, Elizabeth Black, Roni Q Lombardi, Joseph J Higgins. Med Teach 2007
17
50

Missed opportunities: unidentified genetic risk factors in prenatal care.
Trissa McClatchey, Erica Lay, Melissa Strassberg, Ignatia B Van den Veyver. Prenat Diagn 2018
5
50

Process evaluation in randomised controlled trials of complex interventions.
Ann Oakley, Vicki Strange, Chris Bonell, Elizabeth Allen, Judith Stephenson. BMJ 2006
668
50

Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda.
Enola Proctor, Hiie Silmere, Ramesh Raghavan, Peter Hovmand, Greg Aarons, Alicia Bunger, Richard Griffey, Melissa Hensley. Adm Policy Ment Health 2011
50

Are interventions theory-based? Development of a theory coding scheme.
Susan Michie, Andrew Prestwich. Health Psychol 2010
328
50

From Theory-Inspired to Theory-Based Interventions: A Protocol for Developing and Testing a Methodology for Linking Behaviour Change Techniques to Theoretical Mechanisms of Action.
Susan Michie, Rachel N Carey, Marie Johnston, Alexander J Rothman, Marijn de Bruin, Michael P Kelly, Lauren E Connell. Ann Behav Med 2018
113
50

Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic.
Erica M Bednar, Charlotte C Sun, Bethsaida Camacho, John Terrell, Alyssa G Rieber, Lois M Ramondetta, Ralph S Freedman, Karen H Lu. Gynecol Oncol 2019
3
50

Referral for genetic counselling during pregnancy: limited alertness and awareness about genetic risk factors among GPs.
Cora M Aalfs, Ellen M A Smets, Hanneke C J M de Haes, Nico J Leschot. Fam Pract 2003
26
50

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
50


Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
Goli Samimi, Marcus Q Bernardini, Lawrence C Brody, Charlisse F Caga-Anan, Ian G Campbell, Georgia Chenevix-Trench, Fergus J Couch, Michael Dean, Joanne A de Hullu, Susan M Domchek,[...]. J Clin Oncol 2017
33
50

Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer.
F G J Kallenberg, C M Aalfs, F O The, C A Wientjes, A C Depla, M W Mundt, P M M Bossuyt, E Dekker. Fam Cancer 2018
7
50

Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location.
Christine E Koil, Jessica N Everett, Leah Hoechstetter, Rick E Ricer, Karen M Huelsman. Genet Med 2003
34
50


Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic.
Amar U Kishan, Caitlin L Gomez, Nicole A Dawson, Robyn Dvorak, Nova M Foster, Anne Hoyt, Sara A Hurvitz, Amy Kusske, Erica L Silver, Charles Tseng,[...]. Ann Surg Oncol 2016
7
50

Using behaviour change and implementation science to address low referral rates in oncology.
Janet C Long, Deborah Debono, Rachel Williams, Elizabeth Salisbury, Sharron O'Neill, Elizabeth Eykman, Jordan Butler, Robert Rawson, Kim-Chi Phan-Thien, Stephen R Thompson,[...]. BMC Health Serv Res 2018
11
50

A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians.
Maren T Scheuner, Alison B Hamilton, Jane Peredo, Taylor J Sale, Colletta Austin, Stuart C Gilman, M Scott Bowen, Caroline Lubick Goldzweig, Martin Lee, Brian S Mittman,[...]. Genet Med 2014
31
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.